Affluent Medical SA (AFME.PA)
EUR 1.54
(0.99%)
EUR 1.54
(0.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.12 Million | -11.08 Million | -12.36 Million | -8.93 Million | -12.18 Million | -10.84 Million |
| Net Income | -15.65 Million | -15.22 Million | -14.82 Million | -14.31 Million | -16.58 Million | -8.75 Million |
| Depreciation & Amortization | 2.41 Million | 2.34 Million | 2.33 Million | 2.46 Million | 2.26 Million | 353 Thousand |
| Deferred income taxes | - | - | -1.51 Million | -428 Thousand | -5.15 Million | - |
| Stock-based compensation | 731 Thousand | 146 Thousand | 42 Thousand | 959 Thousand | 437 Thousand | - |
| Change in working capital | 235 Thousand | 717 Thousand | -1.13 Million | 612 Thousand | -91 Thousand | -2.44 Million |
| Other non-cash items | 4.89 Million | 935 Thousand | 2.73 Million | 1.77 Million | 6.94 Million | 747 Thousand |
| Investing Cash Flow | -184 Thousand | -146 Thousand | -160 Thousand | -304 Thousand | -185 Thousand | -270 Thousand |
| Investments in PPE | -184 Thousand | -146 Thousand | -334 Thousand | -304 Thousand | -199 Thousand | -263 Thousand |
| Acquisitions | - | - | 174 Thousand | - | 14 Thousand | - |
| Investment purchases | - | - | - | - | - | -7000.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -184 Thousand | - | 174 Thousand | - | 14 Thousand | -38 Thousand |
| Financing Cash Flow | 11.38 Million | 2.4 Million | 18.28 Million | 12.76 Million | 11.16 Million | 14.35 Million |
| Debt repayment | -1.06 Million | -2.46 Million | -5.16 Million | -1.95 Million | -7.35 Million | -2.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.55 Million | 5.74 Million | 21.42 Million | 7.46 Million | 55 Thousand | 9.21 Million |
| Other Financing Activities | 247 Thousand | -872 Thousand | 2.02 Million | 7.24 Million | 3.93 Million | 5.13 Million |
| Accounts receivables | 466 Thousand | -1.33 Million | -1 Million | 1.72 Million | -194 Thousand | -43 Thousand |
| Accounts payables | 352 Thousand | 1.22 Million | -558 Thousand | -1.35 Million | - | - |
| Inventory | - | - | - | -1000.00 | - | - |
| Other working capital | -583 Thousand | 827 Thousand | 424 Thousand | 237 Thousand | 103 Thousand | -2.46 Million |
| Cash at beginning of period | 2.58 Million | 11.4 Million | 5.64 Million | 2.12 Million | 4.87 Million | 1.63 Million |
| Cash at end of period | 1.65 Million | 2.57 Million | 11.4 Million | 5.64 Million | 2.12 Million | 4.87 Million |
| Capital Expenditure | -184 Thousand | -146 Thousand | -334 Thousand | -304 Thousand | -199 Thousand | -263 Thousand |
| Effect of forex changes on cash | - | - | - | - | 3.33 Million | 1000.00 |
| Net cash flow / Change in cash | -922 Thousand | -8.82 Million | 5.75 Million | 3.52 Million | -2.74 Million | 3.24 Million |
| Free Cash Flow | -12.3 Million | -11.22 Million | -12.69 Million | -9.24 Million | -12.38 Million | -11.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.68 Million | -4.68 Million | -3.83 Million | -15.65 Million | -3.83 Million | -7.98 Million |
| Depreciation & Amortization | 601 Thousand | 601 Thousand | 603.5 Thousand | 2.41 Million | 603.5 Thousand | 1.2 Million |
| Deferred income taxes | - | - | - | - | - | -4.5 Million |
| Stock-based compensation | - | - | 212.5 Thousand | 731 Thousand | 212.5 Thousand | 153 Thousand |
| Change in working capital | 3.47 Million | - | 638.5 Thousand | 235 Thousand | 638.5 Thousand | -2.6 Million |
| Other non-cash items | 2.23 Million | 2.23 Million | 620.5 Thousand | 4.89 Million | 620.5 Thousand | 5.17 Million |
| Investing Cash Flow | -32 Thousand | -32 Thousand | -75 Thousand | -184 Thousand | -75 Thousand | -34 Thousand |
| Investments in PPE | -64 Thousand | - | -75 Thousand | -184 Thousand | -75 Thousand | -34 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -32 Thousand | -32 Thousand | -85.5 Thousand | -184 Thousand | -85.5 Thousand | -6500.00 |
| Financing Cash Flow | 1.51 Million | 1.51 Million | -607.5 Thousand | 11.38 Million | -607.5 Thousand | 12.56 Million |
| Debt repayment | -469 Thousand | - | -417 Thousand | -1.06 Million | - | -649 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -114 Thousand | - | -114 Thousand | - |
| Common Stock Issuance | 3.43 Million | - | -228 Thousand | 12.55 Million | - | 12.78 Million |
| Other Financing Activities | 1.51 Million | 1.51 Million | -493.5 Thousand | 247 Thousand | -493.5 Thousand | 609 Thousand |
| Accounts receivables | -1.42 Million | - | 613 Thousand | 466 Thousand | 613 Thousand | -760 Thousand |
| Accounts payables | 674 Thousand | - | 1.53 Million | 352 Thousand | - | -1.18 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.22 Million | - | 25.5 Thousand | -583 Thousand | 25.5 Thousand | -665 Thousand |
| Cash at beginning of period | 1.65 Million | - | 6.54 Million | 2.58 Million | - | 2.58 Million |
| Cash at end of period | 915 Thousand | -371.5 Thousand | 1.65 Million | 1.65 Million | -2.44 Million | 6.54 Million |
| Capital Expenditure | -64 Thousand | - | -75 Thousand | -184 Thousand | -75 Thousand | -34 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 2000.00 |
| Net cash flow / Change in cash | -743 Thousand | -371.5 Thousand | -4.89 Million | -922 Thousand | -2.44 Million | 3.96 Million |
| Free Cash Flow | -1.91 Million | -1.85 Million | -1.83 Million | -12.3 Million | -1.83 Million | -8.6 Million |
SHCAY
9082
KACL
HLEGLAS
002020
2669